Key facts
- This page summarizes Robert J. Bujarski's Form 4 filing for QuidelOrtho Corp (QDEL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Oct 2024, 16:48.
Robert J. Bujarski - 15 Oct 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)
- Reporting relationship
- EVP & COO
- Issuer ticker
- QDEL
- Reported as of
- 15 Oct 2024
- Net transaction value
- -$8,723
- SEC form
- 4
- Accepted by SEC
- 17 Oct 2024, 16:48:32 UTC
- Prior SEC filing
- 17 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Phillip S. Askim, attorney-in-fact for Robert J. Bujarski
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert J. Bujarski filed Form 4 for QuidelOrtho Corp (QDEL) on 17 Oct 2024.
Change
- Previous filing in this sequence was filed on 17 Sep 2024.
- Current net transaction value: -$8,723.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QDEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +390
- Change %
- +0.87%
- Price
- $0.000000
- Shares after
- 45,027
- Date
- 15 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
QDEL
transaction
Common Stock
Tax liability
- Transaction value
- $8,723
- Shares
- -217
- Change %
- -0.48%
- Price
- $40.20
- Shares after
- 44,810
- Date
- 15 Oct 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QDEL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -390
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 390
- Date
- 15 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 390
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Reflects release of restricted stock units that were previously reported on a Form 4.
Footnote F2
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Footnote F3
Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
Footnote F4
390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.